Statement Of Cash Flows [Abstract]

BioPorto - Filing #1413942

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
61,582,000 DKK
53,365,000 DKK
Increase (decrease) in working capital
7,448,000 DKK
15,012,000 DKK
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
4,329,000 DKK
3,994,000 DKK
Income taxes refund, classified as operating activities
5,733,000 DKK
4,743,000 DKK
Finance costs paid, classified as operating activities
1,425,000 DKK
2,640,000 DKK
Finance income received, classified as operating activities
145,000 DKK
634,000 DKK
Cash flows from (used in) financing activities [abstract]
Repayments of non-current borrowings
150,000 DKK
170,000 DKK
Payments for share issue costs
11,000 DKK
16,556,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.